Inhibition of sars coronavirus infection with clinically...

Details Inhibition of sars coronavirus infection with clinically... Inhibition of sars coronavirus infection with clinically...

A - Human Necessities

61

K

A61K 38/21 (2006.01) A61P 11/00 (2006.01)

Patent

CA 2527711

The invention relates to methods for treating or inhibiting SARS-CoV infection involving the administration of an interferon, particularly IFN .alpha.-n1, IFN .alpha.-n3, human leukocyte IFN .alpha. or IFN .beta.-1b.

L'invention concerne des procédés de traitement ou d'inhibition d'une infection par SRAS-CoV faisant intervenir l'administration d'un interféron, notamment de IFN .alpha.-n1, IFN .alpha.-n3, du leucocyte humain IFN .alpha. ou IFN .szlig.-1b.

Affiliated with

Also associated with

Rating

Inhibition of sars coronavirus infection with clinically... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibition of sars coronavirus infection with clinically..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of sars coronavirus infection with clinically... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1345419